NCT03817749View on ClinicalTrials.gov

Ketone Supplementation, Glucose Control, and Cardiovascular Function

NACompletedINTERVENTIONAL
Enrollment

15

Participants

Timeline

Start Date

February 6, 2019

Primary Completion Date

March 1, 2020

Study Completion Date

December 31, 2020

Conditions
Hyperglycemia, PostprandialOverweight and ObesityDiabetes Mellitus Risk
Interventions
DIETARY_SUPPLEMENT

Exogenous ketone monoester

Participants will consume 20g of the oral ketone monoester supplement 15 minutes prior to each meal of the day for 14 days. All meals will be provided throughout the 14-day supplementation period.

Trial Locations (1)

V1V 1V7

University of British Columbia, Okanagan., Kelowna

All Listed Sponsors
lead

University of British Columbia

OTHER

NCT03817749 - Ketone Supplementation, Glucose Control, and Cardiovascular Function | Biotech Hunter | Biotech Hunter